Literature DB >> 33077628

Antibody Opsonization Enhances Early Interactions between Yersinia pestis and Neutrophils in the Skin and Draining Lymph Node in a Mouse Model of Bubonic Plague.

Jeffrey G Shannon1, B Joseph Hinnebusch2.   

Abstract

Bubonic plague results when Yersinia pestis is deposited in the skin via the bite of an infected flea. Bacteria then traffic to the draining lymph node (dLN) where they replicate to large numbers. Without treatment, this infection can result in highly fatal septicemia. Several plague vaccine candidates are currently at various stages of development, but no licensed vaccine is available in the United States. Though polyclonal and monoclonal antibodies (Ab) can provide complete protection against bubonic plague in animal models, the mechanisms responsible for this antibody-mediated immunity (AMI) to Y. pestis remain poorly understood. Here, we examine the effects of Ab opsonization on Y. pestis interactions with phagocytes in vitro and in vivo Opsonization of Y. pestis with polyclonal antiserum modestly increased phagocytosis/killing by an oxidative burst of murine neutrophils in vitro Intravital microscopy (IVM) showed increased association of Ab-opsonized Y. pestis with neutrophils in the dermis in a mouse model of bubonic plague. IVM of popliteal LNs after intradermal (i.d.) injection of bacteria in the footpad revealed increased Y. pestis-neutrophil interactions and increased neutrophil crawling and extravasation in response to Ab-opsonized bacteria. Thus, despite only having a modest effect in in vitro assays, opsonizing Ab had a dramatic effect in vivo on Y. pestis-neutrophil interactions in the dermis and dLN very early after infection. These data shed new light on the importance of neutrophils in AMI to Y. pestis and may provide a new correlate of protection for evaluation of plague vaccine candidates.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Yersinia pestiszzm321990; antibodies; bubonic; humoral immunity; neutrophils; opsonization; plague

Mesh:

Substances:

Year:  2020        PMID: 33077628      PMCID: PMC7927927          DOI: 10.1128/IAI.00061-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  The role of complement in inflammation and adaptive immunity.

Authors:  R Barrington; M Zhang; M Fischer; M C Carroll
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

2.  Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.

Authors:  Alexander V Philipovskiy; Clarissa Cowan; Christine R Wulff-Strobel; Sandra H Burnett; Edward J Kerschen; Donald A Cohen; Alan M Kaplan; Susan C Straley
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis.

Authors:  Céline Pujol; James B Bliska
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein.

Authors:  Sara Schesser Bartra; Katie L Styer; Deanna M O'Bryant; Matthew L Nilles; B Joseph Hinnebusch; Alejandro Aballay; Gregory V Plano
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

5.  Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.

Authors:  S Weeks; J Hill; A Friedlander; S Welkos
Journal:  Microb Pathog       Date:  2002-05       Impact factor: 3.738

6.  Yersinia pestis YadC: a novel vaccine candidate against plague.

Authors:  Brian S Murphy; Christine R Wulff; Beth A Garvy; Susan C Straley
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function.

Authors:  Justin L Spinner; Jennifer A Cundiff; Scott D Kobayashi
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

8.  Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV.

Authors:  Maya I Ivanov; Jim Hill; James B Bliska
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

9.  Dermal neutrophil, macrophage and dendritic cell responses to Yersinia pestis transmitted by fleas.

Authors:  Jeffrey G Shannon; Christopher F Bosio; B Joseph Hinnebusch
Journal:  PLoS Pathog       Date:  2015-03-17       Impact factor: 6.823

Review 10.  Neutrophils and Immunity: From Bactericidal Action to Being Conquered.

Authors:  Tie-Shan Teng; Ai-Ling Ji; Xin-Ying Ji; Yan-Zhang Li
Journal:  J Immunol Res       Date:  2017-02-19       Impact factor: 4.818

View more
  1 in total

1.  Yersiniabactin contributes to overcoming zinc restriction during Yersinia pestis infection of mammalian and insect hosts.

Authors:  Sarah L Price; Viveka Vadyvaloo; Jennifer K DeMarco; Amanda Brady; Phoenix A Gray; Thomas E Kehl-Fie; Sylvie Garneau-Tsodikova; Robert D Perry; Matthew B Lawrenz
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.